Trial Profile

Proellex pharmacokinetic bridging study II

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 14 Jan 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Telapristone (Primary)
Indications Breast cancer; Endometriosis; Uterine leiomyoma
Focus Pharmacokinetics
Sponsors Repros Therapeutics

Most Recent Events

28 Mar 2008 The expected completion date for this trial is now 1 Apr 2008, as reported by clinicaltrials.gov.
28 Mar 2008 Status change from recruiting to in progress, as reported by clinicaltrials.gov.
26 Mar 2008 New trial record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com